Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, MAIA Biotechnology Inc’s stock clocked out at $1.57, up 3.29% from its previous closing price of $1.52. In other words, the price has increased by $3.29 from its previous closing price. On the day, 0.55 million shares were traded. MAIA stock price reached its highest trading level at $1.59 during the session, while it also had its lowest trading level at $1.5201.
Ratios:
To gain a deeper understanding of MAIA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.19 and its Current Ratio is at 2.19. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 01 ’25 when Smith Stan bought 19,230 shares for $1.30 per share. The transaction valued at 24,999 led to the insider holds 1,324,289 shares of the business.
Smith Stan bought 33,333 shares of MAIA for $50,000 on Jun 03 ’25. The Director now owns 1,305,059 shares after completing the transaction at $1.50 per share. On May 08 ’25, another insider, Guerrero Ramiro, who serves as the Director of the company, bought 20,000 shares for $1.50 each. As a result, the insider paid 30,000 and bolstered with 588,218 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MAIA now has a Market Capitalization of 51799356 and an Enterprise Value of 41654832.
Stock Price History:
The Beta on a monthly basis for MAIA is 0.04, which has changed by -0.37698412 over the last 52 weeks, in comparison to a change of 0.1443547 over the same period for the S&P500. Over the past 52 weeks, MAIA has reached a high of $3.48, while it has fallen to a 52-week low of $1.40. The 50-Day Moving Average of the stock is -1.30%, while the 200-Day Moving Average is calculated to be -10.81%.
Shares Statistics:
It appears that MAIA traded 479.19K shares on average per day over the past three months and 907520 shares per day over the past ten days. A total of 31.82M shares are outstanding, with a floating share count of 23.85M. Insiders hold about 27.71% of the company’s shares, while institutions hold 6.92% stake in the company. Shares short for MAIA as of 1759190400 were 714735 with a Short Ratio of 1.49, compared to 1756425600 on 653014. Therefore, it implies a Short% of Shares Outstanding of 714735 and a Short% of Float of 2.5100000000000002.
Earnings Estimates
. The current rating of MAIA Biotechnology Inc (MAIA) is the result of assessments by 1.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is -$0.13, with high estimates of -$0.13 and low estimates of -$0.13.
Analysts are recommending an EPS of between -$0.75 and -$0.75 for the fiscal current year, implying an average EPS of -$0.75. EPS for the following year is -$0.69, with 1.0 analysts recommending between -$0.69 and -$0.69.
